UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.78B |
| 2 |
NVIDIA
NVDA
|
+$3.34B |
| 3 |
Apple
AAPL
|
+$2.76B |
| 4 |
UBS Group
UBS
|
+$2.65B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.03B |
| 2 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.25B |
| 3 |
Pinduoduo
PDD
|
+$1.4B |
| 4 |
Linde
LIN
|
+$919M |
| 5 |
Prologis
PLD
|
+$865M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.34% |
| 2 | Healthcare | 12.59% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.26% |
| 5 | Communication Services | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Heritage Financial
HFWA
$1.21B
| $1.01M | ﹤0.01% |
56,102
+13,556
| +32% | +$243K |
|
2327
Cipher Digital
CIFR
$7.13B
| $1M | ﹤0.01% |
241,900
+177,588
| +276% | +$735K |
|
2328
Mercantile Bank Corp
MBWM
$1.05B
| $1M | ﹤0.01% |
24,722
+10,735
| +77% | +$402K |
|
2329
4D Molecular Therapeutics
FDMT
$562M
| $1M | ﹤0.01% |
47,652
+15,574
| +49% | +$391K |
|
|
SEMR
2330
DELISTED
Semrush
SEMR
| $999K | ﹤0.01% |
74,574
+15,585
| +26% | +$216K |
|
2331
Manitowoc
MTW
$675M
| $994K | ﹤0.01% |
86,183
+9,943
| +13% | +$123K |
|
2332
Establishment Labs
ESTA
$2.28B
| $992K | ﹤0.01% |
21,820
-5,876
| -21% | -$298K |
|
2333
NextDecade
NEXT
$1.78B
| $991K | ﹤0.01% |
124,839
+51,025
| +69% | +$351K |
|
2334
Clear Channel Outdoor Holdings
CCO
$1.23B
| $989K | ﹤0.01% |
701,437
+293,814
| +72% | +$433K |
|
2335
Taboola.com
TBLA
$1.11B
| $986K | ﹤0.01% |
286,689
+158,418
| +124% | +$639K |
|
|
APO.PRA
2336
DELISTED
Apollo Global Management Series A
APO.PRA
| $984K | ﹤0.01% |
+15,000
| New | +$957K |
|
2337
First Financial Corp
THFF
$969M
| $974K | ﹤0.01% |
26,423
+10,167
| +63% | +$373K |
|
|
DHIL
2338
DELISTED
Diamond Hill
DHIL
| $971K | ﹤0.01% |
6,900
+4,402
| +176% | +$661K |
|
2339
Vicor
VICR
$10.2B
| $969K | ﹤0.01% |
29,229
+14,027
| +92% | +$484K |
|
2340
Zai Lab
ZLAB
$2.62B
| $969K | ﹤0.01% |
55,914
+37,743
| +208% | +$664K |
|
2341
Anterix
ATEX
$1.94B
| $969K | ﹤0.01% |
24,473
+10,781
| +79% | +$349K |
|
2342
Dream Finders Homes
DFH
$1.36B
| $964K | ﹤0.01% |
37,353
+14,257
| +62% | +$451K |
|
|
FBRT
2343
Franklin BSP Realty Trust
FBRT
$657M
| $964K | ﹤0.01% |
76,498
-17,984
| -19% | -$229K |
|
2344
ARKO Corp
ARKO
$635M
| $963K | ﹤0.01% |
153,526
+109,303
| +247% | +$588K |
|
|
DAWN
2345
DELISTED
Day One Biopharmaceuticals
DAWN
| $961K | ﹤0.01% |
69,730
+31,851
| +84% | +$466K |
|
|
EB
2346
DELISTED
Eventbrite
EB
| $961K | ﹤0.01% |
198,507
+83,935
| +73% | +$438K |
|
2347
First Community Bankshares
FCBC
$911M
| $960K | ﹤0.01% |
26,071
+6,811
| +35% | +$231K |
|
|
SLNO
2348
DELISTED
Soleno Therapeutics
SLNO
| $960K | ﹤0.01% |
23,531
+14,707
| +167% | +$623K |
|
2349
Phathom Pharmaceuticals
PHAT
$692M
| $959K | ﹤0.01% |
93,154
+80,261
| +623% | +$827K |
|
|
MFA
2350
MFA Financial
MFA
$933M
| $958K | ﹤0.01% |
90,032
-19,625
| -18% | -$211K |
|
Similar funds
UBS AM's Q2 2024 Portfolio in Review
As of Q2 2024, UBS AM held 2,913 positions worth $349B, up 24% from $281B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
UBS AM deployed $57B of net new capital in Q2 2024, opening 370 new positions and adding to 2,061 existing holdings. Its largest new stake was UBS Group: 89,043,128 shares worth $2.63B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core MSCI EAFE ETF, an estimated $4.03B trimmed.
- UBS AM's largest Q2 2024 buy was UBS Group: 89,043,128 shares worth $2.63B.
- UBS AM added most to Microsoft in Q2 2024, an estimated $4.78B increase.
- UBS AM's biggest Q2 2024 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $4.03B.
- UBS AM fully exited iShares Broad USD Investment Grade Corporate Bond ETF in Q2 2024, selling an estimated $2.25B.
- UBS AM's ten largest holdings make up 31% of its $349B portfolio in Q2 2024.
- UBS AM opened 370 new positions and closed 119 in Q2 2024.
- UBS AM's portfolio value rose 24% quarter-over-quarter to $349B.
Based on UBS AM's 13F filing for Q2 2024, filed 14 Aug 2024.